Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopofol vs propofol vasodilation assessed by perfusion index
ChiCTR2400094336Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Dec 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Cyclopofol group with Propofol group (2 arms). Primary endpoint: Perfusion index (PI). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ciprofolpropofol
Beyond the preview
Go deeper on ChiCTR2400094336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094336.